Irvine, California, August 14, 2023

A promising molecular diagnostic tool for detecting primary bladder cancer in patients who notice blood in their urine may speed up diagnosis and reduce the need for potentially unnecessary cystoscopies, report investigators in The Journal of Molecular Diagnostics.

Bladder cancer has a five-year survival rate of over 80% when detected early, but this rate declines significantly as the disease progresses to advanced stages. In a novel study in The Journal of Molecular Diagnostics, published by Elsevier, investigators report on a promising new diagnostic tool that may pave the way for an important breakthrough in early diagnosis of bladder cancer in patients with blood in their urine (hematuria), reducing the number of potentially unnecessary invasive cystoscopies and alleviating the economic burden of the disease.

…

Read the rest of the article here.